Donnelley Financial Solutions

Centerline Capital Group, a subsidiary of Centerline Holding Company, is an alternative asset manager with a core focus on real estate and more than $14 billion of assets under management. Centerline Capital Group represents the combined expertise of CharterMac and ARCap, two industry leaders in real estate investment and finance. The company provides capital at various layers of a property's capital structure and investment products at different levels of the risk spectrum. Centerline has operated in various forms for over 35 years and has a track record of performing through a spectrum of economic and real estate cycles. Centerline Capital Group has over 475 employees in more than five offices throughout the United States, including a location in New York.

Balyasny Asset Management is a multi-strategy asset management firm based in New York, NY, aiming to deliver consistent uncorrelated returns across various market environments. With $25 billion in assets under management and a team of 1,700 investment professionals spread across 20 global locations, the firm prioritizes differentiated investment ideas and a culture of partnership among its teams and investors. The firm employs specialized Investment, Risk, Technology, and Business Infrastructure Teams to manage and enhance its investment strategies. By leveraging advanced analytics and artificial intelligence, Balyasny fosters proactive risk management and operational efficiency, positioning itself as a leader in the asset management industry. Generated from the website

Ferghana Partners is a leading specialist investment banking group delivering high quality, senior level advice to the global Healthcare and Chemicals Sectors for value-added Corporate Partnering, M&A and Equity Financing Transactions. Ferghana Partners Group ( "FPG" ) is an international provider of high level, independent corporate finance advice to firms in the Biotechnology, Pharmaceuticals, Diagnostics and Specialty Chemicals industries which together comprise the Life Sciences field.